Smokerlyzer® registration with Medicah S.A.S in Colombia boosts quit-smoking services in the region.
Bedfont® Scientific Limited, an innovative MedTech company with nearly 50 years of experience in the breath analysis industry, is pleased to collaborate with Medicah S.A.S through a new registration for the Smokerlyzer® range of carbon monoxide (CO) monitoring devices. The partnership aims to improve smoking cessation services across Colombia.
Bedfont® has been helping people to quit smoking with its Smokerlyzer® range for over 40 years. The Smokerlyzer® range measures levels of CO in parts per million (ppm) on exhaled breath, helping to establish a person’s smoking status. Monitoring CO levels and seeing them drop during a quit attempt provides smokers with a motivational aid to quit smoking.
Medicah S.A.S, a distributor of medical technology, supports hospitals, clinics and diagnostic providers through product supply and after-sales service. Already a distributor of the Bedfont® NObreath® Fractional exhaled Nitric Oxide (FeNO) device, Medicah S.A.S. is chosen for its shared commitment to improving patient outcomes, with the Smokerlyzer® range an important addition to its product catalogue.
“We are delighted to expand our partnership with Medicah through the registration of our Smokerlyzer® range in Colombia. Having successfully worked together to bring our NObreath® to healthcare professionals across the region, we are proud that this latest addition strengthens Medicah’s respiratory diagnostics portfolio and reinforces our shared commitment to improving patient care.” Said Jason Smith, CEO at Bedfont®.
CO monitoring plays a vital role in smoking cessation programmes and respiratory health management, providing clinicians with an objective and immediate measure to support behaviour change and treatment decisions.
Whilst Colombia is considered a relatively low-smoking country in Latin America, the latest registration of the Smokerlyzer® range of CO monitoring devices provides an additional tool, making this technology more widely available, allowing healthcare providers to deliver more effective interventions and improve patient outcomes throughout Colombia and the surrounding areas.
To learn more about the Smokerlyzer® range of CO monitoring devices, visit the website here.
